Results from phase III LUNAR study of LBN 0.024% in open-angle glaucoma or ocular hypertension July 11, 2016 No Comments
Otsuka Pharmaceutical terminates emixustat and OPA-6566 agreements with Acucela June 14, 2016 No Comments
Eleven Biotherapeutics submits IND for EBI-031, licenses IL-6 technology to Roche June 14, 2016 No Comments
RSS